Plasma p-tau217 as a two-cutoff approach to improve tau-PET screening and trial recruitment in Alzheimer's disease

More on p-Tau217

• Lifestyle trial found similar Alzheimer’s blood marker changes

  medRxiv · 7 Oct 2026

  

• Stronger rest-activity rhythms link to better executive function

  Frontiers in Aging Neuroscience · 4 Oct 2026

• Speech age gaps track dementia phenotypes and biological aging

  Science Advances · 2 Oct 2026

  

• Plasma p-tau217 yields discordant Alzheimer results in 8.5% of adults

  Neurology · 4 Oct 2026